Accueil / Tag Archives: Medical Devices

Tag Archives: Medical Devices

InDevR Launches Next-Generation Software for the Cypher One™ System

Tuesday, March 21st 2017 at 10:00am UTC Next Generation Cypher One™ Software Increases Functionality and Ensures Data Integrity for the Standardization of Hemagglutination and Hemagglutination Inhibition Assays BOULDER, Colo.–(BUSINESS WIRE)– InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, today announced the global launch of …

Plus »

InVivo Therapeutics Announces Enrollment of New Patient into the INSPIRE Study at New Jersey’s Cooper Neurological Institute

Monday, March 20th 2017 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (NVIV) today announced that a new patient has been enrolled into The INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord …

Plus »

Thermo Fisher Scientific Showcases Newest Bioprocessing Technologies at INTERPHEX

Monday, March 20th 2017 at 12:00pm UTC Integrated products, software and services designed to increase customer innovation and productivity NEW YORK–(BUSINESS WIRE)– INTERPHEX 2017 – Thermo Fisher Scientific, the world leader in serving science, today announced it is featuring its latest bioprocessing technologies at the International Pharmaceutical Expo (INTERPHEX) at …

Plus »

Metactive Medical Announces Issuance of Patents on Blockstent and Ballstent Embolization Devices

Tuesday, March 21st 2017 at 12:30pm UTC Company Closes Additional Series A Financing OLATHE, Kan.–(BUSINESS WIRE)– Metactive Medical Inc. (Metactive), an early-stage company focused on developing embolization devices for the treatment of peripheral vascular and neurovascular diseases, today announced the issuance of US Patents 9,572,697 and 9,572,698 covering its Ballstent …

Plus »

Cerulean Pharma and Daré Bioscience Enter into Stock Purchase Agreement

Monday, March 20th 2017 at 12:00pm UTC Transaction to create NASDAQ-listed company focused on the development and commercialization of women’s reproductive health products Sabrina Martucci Johnson to be Named CEO of Combined Company Cerulean and Daré to Host Joint Conference Call in March to Discuss Proposed Transaction and Dare’s Business …

Plus »

ZOLL Receives Health Canada Approval for Two New Models Of AEDS

Tuesday, March 21st 2017 at 5:03pm UTC Expands Lifesaving Portfolio with Enhanced Real CPR Help and Program Management Onboard CHELMSFORD, Mass.–(BUSINESS WIRE)– ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that Health Canada has approved the ZOLL AED 3™* and …

Plus »

Novocure Receives MHLW Approval for Second Generation Optune® in Japan

Monday, March 20th 2017 at 11:00am UTC Second generation Optune is now approved in all active Novocure markets Optune is the first MHLW-approved therapy in more than a decade to demonstrate statistically and clinically significant extension of survival in newly diagnosed GBM patients ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ:NVCR) today …

Plus »

New Comprehensive Carrier Screening Research Assay Features Richest Pan-Ethnic Panel for Detection of Multiple Genetic Variations in Inherited Disease

Tuesday, March 21st 2017 at 12:00pm UTC CarrierScan™ Assay from Thermo Fisher Scientific consolidates conventional multi-assay approach for “all-in-one” research CARLSBAD, Calif. & PHOENIX–(BUSINESS WIRE)– A new high-throughput, microarray-based assay designed to detect more than 6,000 genomic variations associated with inherited disease now provides molecular genetics laboratories with a consolidated …

Plus »

Endocrine Disrupting Chemicals Identified Using xCELLigence® Real-Time Cell Analysis

Monday, March 20th 2017 at 9:00am UTC ACEA Biosciences develops novel assay for the rapid and facile detection of agonists and antagonists of key endocrine receptors SAN DIEGO–(BUSINESS WIRE)– Endocrine-disrupting chemicals (EDCs) are substances that interfere with the ability of endogenous hormones to regulate homeostasis via their cognate nuclear receptors. …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
Retrouvez nous sur
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...